Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07004907
NA

Efficacy and Tolerability of the APD Treatment in PAED Patients

Sponsor: Fresenius Medical Care Deutschland GmbH

View on ClinicalTrials.gov

Summary

The Silencia PD (peritoneal dialysis) cycler offers a pediatric (PAED) mode with advanced features such as Time and Volume Optimization (TAVO), supporting precise and individualized treatment. This study evaluates the efficacy and tolerability of Automated Peritoneal Dialysis (APD) using the Silencia PD cycler in patients weighing ≤ 20 kg and able to tolerate a minimum inflow volume of 100 mL. The primary objective is to determine whether patients achieve a total weekly Kt/Vurea ≥ 1.8.

Official title: Efficacy and Tolerability of the APD Treatment of Toddlers and Newborns With the Silencia PD Cycler

Key Details

Gender

All

Age Range

0 Months - Any

Study Type

INTERVENTIONAL

Enrollment

13

Start Date

2026-01

Completion Date

2026-11

Last Updated

2025-06-04

Healthy Volunteers

No

Interventions

DEVICE

Treatment with the pedriatic mode of the APD cycler

Patients weighing less than 20 kg will be treated for 4 weeks with APD using the PAED mode of the Silencia PD cycler